Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Emeren Announces Fourth Quarter and Full Year 2024 Financial Results 2025-03-14 04:01
MicroAlgo Inc. Develops Quantum Neural Networks Integrated with Grover's Algorithm to Enhance Big Data Search Efficiency 2025-03-13 23:45
Hesai Secures New Lidar Design Win with a Top 5 Chinese NEV Automaker, Entering Mass Production Phase this Year 2025-03-13 22:00
OTOKI Unveils 'Jin Ramen Campaign' Video Featuring BTS' Jin, Launching Global Campaign 2025-03-13 21:00
Christopher Nixon Cox Named Chairman of High-Trend International Group 2025-03-13 21:00
Hyundai Mobis declares a new vision: Lead the Shift in Mobility, Move the World beyond Possibilities 2025-03-13 20:00
Yiren Digital to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 2025-03-13 18:41
Mega Matrix Inc. and 9 Yards Cinema Production established JV ahead of $100M 'Short Drama Investment Fund' launch 2025-03-13 18:30
Sohu.com Limited Announces its 2024 Annual Report on Form 20-F is Available on the Company's Website 2025-03-13 18:17
Amcor prices private offering of $2.2 billion of senior unsecured notes 2025-03-13 18:11
Noah to Report Fourth Quarter and Full Year 2024 Unaudited Financial Results on March 25, 2025 2025-03-13 18:00
ChipMOS to Present at BofA Securities 2025 Asia Tech Conference 2025-03-13 18:00
Weibo Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and Annual Dividend 2025-03-13 17:00
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share 2025-03-13 16:46
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 2025-03-13 13:54
Ping An Health Reports First Full-Year Profit in 2024 2025-03-13 09:31
Hanwha Aerospace Receives DNV AIP Certification on Hydrogen Fuel Cells 2025-03-13 09:12
STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States 2025-03-13 07:30
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy 2025-03-13 07:30
Baijiayun Group Ltd Announces the Appointment of Independent Directors 2025-03-13 05:00
1 145 146 147 148 149 2413